BLUE

bluebird bio, Inc. (BLUE) ESG Analysis Analysis (2026)

Invetso Score: 5.5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.6 (Moderate)

BLUE’s R&D intensity versus revenue suggests some product-development commitment, but the metric alone does not indicate a peer-leading environmental strategy or outcomes.

No direct emissions, energy, water, or waste disclosures were provided, limiting evidence that BLUE is materially better positioned than peers on core environmental risks.

The available metrics do not show environmental liabilities or transition exposure, yet the absence of peer-comparable sustainability data prevents a stronger relative assessment.

Overall environmental positioning appears mixed versus peers because there is limited evidence of structured environmental advantage, despite no clear sign of structural environmental weakness.

Social

Score:

BLUE’s stock-based compensation burden is meaningful, which can support talent retention, but it also suggests a compensation structure that is not clearly superior to peers.

The provided data do not include workforce safety, turnover, diversity, or customer-impact metrics, so relative social performance cannot be established as above peer average.

R&D spending can support product quality and user outcomes, but without evidence on responsible product governance, the social benefit remains only partially demonstrated.

Overall social positioning is moderate because the available indicators imply some human-capital investment, yet they do not show a clear advantage over peers.

Governance

Score:

The negative debt-to-equity and net-debt-to-EBITDA figures suggest a balance-sheet structure that is not directly interpretable as governance strength, limiting peer-relative confidence.

Stock-based compensation at 16.4% of revenue is relatively high, which can dilute alignment if not tightly governed and appears less disciplined than stronger peers.

The absence of board, audit, ownership, and controversy data materially constrains governance assessment, preventing evidence of a peer-leading control environment.

Overall governance scores below stronger peers because the available metrics show limited transparency and no clear proof of superior oversight or capital-allocation discipline.

Overall Score

Score:

BLUE’s ESG profile is moderate versus peers because the available data show some investment in innovation and human capital, but little evidence of structural ESG leadership.

Score Driver: Limited Disclosure On Core ESG Metrics Prevents Evidence Of A Peer-Leading Position.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on bluebird bio, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →